Label: DIFFERIN 10% BPO ACNE TREATMENT- benzoyl peroxide solution

  • NDC Code(s): 0299-4611-00
  • Packager: Galderma Laboratories, L.P.
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated June 6, 2024

If you are a consumer or patient please visit this version.

  • Active Ingredients

     Benzoyl Peroxide 10% 

  • Purpose

    Acne treatment

  • Uses

    For the treatment of acne                 

  • Warnings

    For external use only.

    Do not use if you
    ■ have very sensitive skin
    ■ are sensitive to benzoyl peroxide

    When using this product
    ■ skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
    ■ avoid unnecessary sun exposure and use a sunscreen
    ■ avoid contact with the eyes, lips, and mouth
    ■ avoid contact with hair and dyed fabrics, which may be bleached by this product
    ■ skin irritation may occur, characterized by redness, burning, itching, peeling, or possibly swelling. Irritation may be reduced by using the product less frequently or in a lower concentration.

    Stop use and ask a doctor if
    ■ irritation becomes severe.

  • KEEP OUT OF REACH OF CHILDREN

    Keep out of reach of children.
    If swallowed, get medical help or contact a Poison Control Center right away.

  • Directions

    Sensitivity Test for a New User. Apply product sparingly to one or two small affected areas during the first 3 days. If no discomfort occurs, follow the directions stated below ■ clean the skin thoroughly before applying this product ■ cover the entire affected area with a thin layer one to three times daily ■  because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor ■ if bothersome dryness or peeling occurs, reduce application to once a day or every other day ■ if going outside, apply sunscreen after using this product. If irritation or sensitivity develops, stop use of both products and ask a doctor

  • Inactive Ingredients

    Acrylates Copolymer, Carbomer, Diethylhexyl Sodium Sulfosuccinate, Disodium EDTA, Glycerin, Poloxamer 182, Propylene Glycol, Silica, Sodium Hydroxide, Water

  • STORAGE AND HANDLING

  • Questions or comments?

    1-866-735-4137

  • QUESTIONS

    Distributed by:

    Galderma Laboratories, L.P.

    Dallas, TX 75201
    USA

    All trademarks are the property of their respective owners

    Made in Canada

    www.differin.com


  • Principle Display Panel -   1 OZ (28 g) carton

    P57672-0 carton image

    NEW

    DIFFERIN®                 
    Acne

    Spot
    Treatment
    10%
    BENZOYL
    PEROXIDE
    Acne Treatment

    MAXIMUM STRENGTH
    Reduces Acne Size & Redness
    VISIBLE RESULTS AFTER 1 DAY


    NET WT 1 OZ (28 g)
    P57672-0









  • INGREDIENTS AND APPEARANCE
    DIFFERIN 10% BPO ACNE TREATMENT 
    benzoyl peroxide solution
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0299-4611
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    Benzoyl Peroxide (UNII: W9WZN9A0GM) (Benzoyl Peroxide - UNII:W9WZN9A0GM) Benzoyl Peroxide10 g  in 100 g
    Inactive Ingredients
    Ingredient NameStrength
    Butyl Acrylate/Methyl Methacrylate/Methacrylic Acid Copolymer (18000 Mw) (UNII: JZ1374NL9E)  
    Carbomer Homopolymer, Unspecified Type (UNII: 0A5MM307FC)  
    Docusate Sodium (UNII: F05Q2T2JA0)  
    Edetate Disodium Anhydrous (UNII: 8NLQ36F6MM)  
    Glycerin (UNII: PDC6A3C0OX)  
    Poloxamer 182 (UNII: JX0HIX6OAG)  
    Propylene Glycol (UNII: 6DC9Q167V3)  
    Silicon Dioxide (UNII: ETJ7Z6XBU4)  
    Sodium Hydroxide (UNII: 55X04QC32I)  
    Water (UNII: 059QF0KO0R)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0299-4611-001 in 1 BOX06/06/2024
    128 g in 1 TUBE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM00606/06/2024
    Labeler - Galderma Laboratories, L.P. (047350186)
    Establishment
    NameAddressID/FEIBusiness Operations
    G Production Inc.251676961manufacture(0299-4611)